BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2961579)

  • 1. Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT.
    Stewart B; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1987 Oct; 142(1):173-6. PubMed ID: 2961579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pilocarpine and oxotremorine on oestrous behaviour in female rats after treatment with monoamine depletors or monoamine synthesis inhibitors.
    Lindstrom LH
    Eur J Pharmacol; 1971 Jun; 15(1):60-5. PubMed ID: 4265962
    [No Abstract]   [Full Text] [Related]  

  • 3. Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine.
    Reches A; Hassan MN; Jackson VR; Fahn S
    Life Sci; 1983 Jul; 33(2):157-60. PubMed ID: 6865653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological analysis of the neurotransmitter mechanisms regulating phenylethanolamine N-methyltransferase in the adrenal gland.
    Lima L; Sourkes TL
    Biochem Pharmacol; 1986 Nov; 35(22):3965-9. PubMed ID: 2946301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S; Bolle P; Modigh K
    Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of serotonin in the nicotine-induced depression of the brainstem auditory evoked response.
    Bhargava V; Salamy A; Shah S
    Pharmacol Biochem Behav; 1981 Oct; 15(4):587-9. PubMed ID: 6457306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of monoamines in the behavioural effects of kainic acid in rats.
    Lenicque PM; Wepierre J; Cohen Y
    J Neural Transm; 1981; 51(3-4):205-12. PubMed ID: 6116744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat.
    Stewart BR; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1988; 96(1):55-62. PubMed ID: 2906443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long lasting supersensitivity to 5-HT mediated behaviour following monoamine depletion in the rat brain.
    Rényi L
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):298-302. PubMed ID: 2948371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamines and the mechanisms of action of antitussive drugs in rats.
    Kamei J; Ogawa M; Kasuya Y
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):117-27. PubMed ID: 2965557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of different amphetamines on copulatory behaviour and stereotype activity in the female rat, after treatment with monoamine depletors and synthesis inhibitors.
    Michanek A; Meyerson BJ
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):301-12. PubMed ID: 145834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoaminergic mechanism of electroacupuncture analgesia.
    Cheng RS; Pomeranz B
    Brain Res; 1981 Jun; 215(1-2):77-92. PubMed ID: 6114781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of physical dependence on barbiturates and cerebral monoamines.
    Tagashira E; Hiramori T; Urano T; Yanaura S
    Jpn J Pharmacol; 1983 Apr; 33(2):415-22. PubMed ID: 6193305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitatory effects of monoamine synthesis inhibitors on lysine-vasopressin induced changes in the exploratory behaviour pattern of male rats.
    Höglund AU; Meyerson BJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):859-63. PubMed ID: 6097918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by serotonin of glutamate-induced lethality in mice.
    Kamei J; Igarashi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):167-84. PubMed ID: 1839809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system.
    Pan HS; Wang RY
    Brain Res; 1991 Mar; 543(1):56-60. PubMed ID: 1675924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.